Finance

Beta
Lists
DRMAW:NASDAQ
Dermata Therapeutics Inc
$0.014
0.00%
(0.00) 1D
May 28, 3:30:31 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DRMAW...
Mkt. cap
5.23M
Avg. vol.
2.81K
Volume
0.00
52-wk high
$0.03
52-wk low
$0.01
Beta
1.34
No. of employees
9
Mkt. cap
5.23M
Avg. vol.
2.81K
Volume
0.00
52-wk high
$0.03
52-wk low
$0.01
Beta
1.34
No. of employees
9
News stories
From sources across the web
About Dermata Therapeutics Inc
CEO-
Employees9
Founded2014
Headquarters-
SectorBiotechnology
Websitedermatarx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
617.84K
504.39K
526.62K
383.72K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.15M
1.26M
1.37M
1.54M
Operating expense
1.77M
1.76M
1.90M
1.93M
Total operating expenses
1.77M
1.76M
1.90M
1.93M
Operating income
-1.77M
-1.76M
-1.90M
-1.93M
Other non operating income
-
-
-
-
EBT including unusual items
-1.70M
-1.69M
-1.86M
-1.85M
EBT excluding unusual items
-1.70M
-1.69M
-1.86M
-1.85M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.70M
-1.69M
-1.86M
-1.85M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
71.64K
68.68K
38.50K
78.68K
Interest expense
-
-
-
-
Net interest expenses
71.64K
68.68K
38.50K
78.68K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer